A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2017.12.003
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Elsevier BV